UCL researchers develop an AI tool to predict brain tumor MRI enhancement, reducing the need for gadolinium contrast agents.
Key Details
- 1AI tool designed to predict which brain tumor areas would enhance with contrast on MRI.
- 2Developed by a team at University College London (UCL).
- 3Tool aims to minimize unnecessary exposure to gadolinium-based contrast agents (GBCAs).
- 4GBCAs can accumulate in the body and are a concern for patients with kidney disease, allergies, or those needing frequent follow-ups.
- 5Model validated to work from non-contrast MRI sequences alone.
Why It Matters
Reducing routine use of GBCAs may lower patient risk, especially among those with renal impairment or allergies, while still enabling accurate tumor monitoring. AI-driven solutions like this offer a path toward safer and more efficient MR imaging protocols in oncology.
Source
Radiology Business
Related News
•AuntMinnie
Open-Source AI Platform Powers Pediatric Bone and Fetal MRI Pipelines
Open-source AI platform successfully integrated and sustained two pediatric imaging pipelines for bone length and fetal MRI at a children's hospital.
•Radiology Business
Meta Funds Ohio State’s Radiology AI Innovation Projects
Meta will fund Ohio State researchers to explore AI-driven advancements in radiology, including chest X-ray reporting and disease prediction.
•AuntMinnie
ChatGPT-5 Performs Poorly at Detecting Distal Radius Fractures on X-rays
ChatGPT-5 missed about half of distal radius fractures on x-rays, showing limited diagnostic capability in a real-world scenario.